Gallbladder Cancer
📧 Sign up to get email alerts when something new happens for Gallbladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: NGS in Gallbladder Cancer and Response to Treatment
Recruitment is ongoing for Banaras Hindu University’s study evaluating next-generation sequencing in gallbladder cancer and its response to …
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer [Phase 2]
Phase II clinical trial evaluating SHR-A1811 in patients with HER2-expressing or HER2-amplified biliary tract cancer; recruitment is ongoing…
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer [NA]
A clinical trial is evaluating wedge resection and IVb/V resection of the liver for gallbladder cancer and is currently recruiting at Saint …
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs [Phase 2]
A Phase II, single-arm trial evaluating camrelizumab in combination with GEMOX for unresectable gallbladder cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial investigating a combination of hepatic artery infusion chemotherapy (HAIC), surufatinib, and tislelizumab for unresec…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Pembrolizumab in Biliary Tract Cancer [Phase 2]
Phase 2 trial update of pembrolizumab in biliary tract cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC [Phase 2]
Phase 2 trial evaluating Envafolimab in combination with GEMOX as first-line treatment for advanced gallbladder cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer [Phase 3]
Phase 3 trial evaluating gemcitabine with or without capecitabine in locally advanced, unresectable, or metastatic biliary cancer was termin…
-
CLINICAL_TRIALS trial_result · 2023-06-23Clinical Trial Update: HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC [Phase 2]
A Phase 2 trial evaluating hepatic arterial infusion chemotherapy with oxaliplatin, 5-fluorouracil, and bevacizumab in combination with intr…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery [Phase 2]
Phase 2 clinical trial evaluating ramucirumab in advanced or metastatic biliary cancers that cannot be removed surgically; results completed…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer [NA]
Clinical trial update for M5A, a Copper-64 labeled anti-CEA monoclonal antibody used in PET imaging to diagnose CEA-positive cancers; the st…
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1) [Phase 3]
Phase 3 TOPAZ-1 trial results for durvalumab in combination with gemcitabine/cisplatin in first-line biliary tract cancer have been posted.
-
CLINICAL_TRIALS trial_result · 2022-11-17Clinical Trial Update: Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC. [Phase 2]
Phase 2 trial comparing tislelizumab plus lenvatinib and GEMOX versus tislelizumab plus GEMOX for conversion therapy in potentially resectab…
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer [Phase 2]
Phase 2 trial updating efficacy/safety of trifluridine/tipiracil plus irinotecan for advanced refractory biliary tract cancer; results poste…
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration [Phase 2]
Phase 2 trial comparing current hydration regimen for the ABC02 chemotherapy regimen to a shorter hydration approach in gallbladder cancer.
-
CLINICAL_TRIALS trial_result · 2022-06-13Clinical Trial Update: Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC [Phase 2, Phase 3]
Phase 2/3 trial evaluating gemcitabine plus cisplatin with or without bintrafusp alfa (M7824) in first-line biliary tract cancer; study term…
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Tisleizumab Combined With Lenvatinib and XELOX Regimen (Oxaliplatin Combined With Capecitabine) in the First-line Treatment of Advanced and Unresectable Biliary Tract Tumors [Phase 2]
Phase 2 trial evaluating tisleizumab with lenvatinib and XELOX in first-line treatment of advanced unresectable biliary tract tumors.
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) [Phase 2]
Phase 2 trial of M7824 monotherapy in second-line biliary tract cancers (cholangiocarcinoma and gallbladder cancer) has completed with resul…
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial update for MRG002 in HER2-positive biliary tract cancer (advanced/metastatic, unresectable).
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Programs To Support You During Chemotherapy [NA]
A completed clinical trial sponsored by Wake Forest University Health Sciences focused on providing support during chemotherapy, with result…
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with CAPOX for advanced biliary tract cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line [Phase 2]
Phase 2 trial comparing mFOLFOX vs. mFOLFIRI in advanced or recurrent biliary tract cancer refractory to first-line therapy has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating first-line gemcitabine, cisplatin, and MEK162 in advanced biliary tract carcinoma has completed with results po…
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer [Phase 2]
A Phase 2 clinical trial evaluating adjuvant immunotherapy in combination with chemoradiation for high-risk resectable biliary tract cancers…
-
CLINICAL_TRIALS withdrawal · 2020-06-05Clinical Trial Update: Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer [Phase 3]
Phase 3 trial evaluating chemotherapy before and after surgery for resectable gallbladder cancer was withdrawn.